Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protease serine 2 (TMPRSS2) is a type II transmembrane serine protease that plays a critical role in viral entry, particularly for coronaviruses like SARS-CoV and SARS-CoV-2, by priming viral spike proteins. It is also implicated in prostate cancer through gene fusions with ETS transcription factors. TMPRSS2 contains several domains, including a cytosolic tail, transmembrane region, LDLRA domain, SRCR domain, and a serine protease domain with a catalytic triad of His296, Asp345, and Ser441. Inhibitors like camostat mesylate (ineffective against COVID-19) and N‑0385 target its serine protease activity.
Serine protease inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protease, serine 2 (TMPRSS2).